TP53 mutations occur early in glioma progression, and grade II astrocytomas commonly display TP53 mutations or loss of heterozygosity on chromosome 17p where TP53 resides [15, 16]. This evidence concerns the gene TP53 and astrocytoma (excluding glioblastoma).